Research on FRα has focused on identification of tumor types that show FRα overexpression and a recent study showed that 40% of epithelial tumors show FRα overexpression, including (non-mucinous) ovarian, kidney, uterine, colon, lung and breast cancer [10]. Here, FOLR1 is linked to breast carcinoma.